Present-day investigations cannot adequately determine the risk of acute coronary syndromes

Clinical Laboratory

Volumn 47, Issue 5-6, 2001, Pages 257-263

  Foo, R S Y ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; FIBRIN; LIPID; MATRIX METALLOPROTEINASE;

ACUTE DISEASE; ANGIOCARDIOGRAPHY; ANGIOSCOPY; ARTERY ENDOTHELIUM; ATHEROSCLEROTIC PLAQUE; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOWN REGULATION; ENZYME ACTIVITY; EXERCISE ELECTROCARDIOGRAPHY; HUMAN; MACROPHAGE ACTIVATION; PATHOGENESIS; REVIEW; RISK; SMOOTH MUSCLE FIBER; STRESS ECHOCARDIOGRAPHY; T LYMPHOCYTE ACTIVATION; THROMBOCYTE; THROMBOSIS;

ARTERIOSCLEROSIS; COLLAGEN; CORONARY ANGIOGRAPHY; CORONARY DISEASE; ELECTROCARDIOGRAPHY; EXERCISE TEST; HUMANS; MACROPHAGE ACTIVATION; MATRIX METALLOPROTEINASES; MUSCLE, SMOOTH, VASCULAR; RISK FACTORS; T-LYMPHOCYTES;

THROMBUS;

EID: 0034981105     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Mechanisms leading to myocardial infarction: Insights from studies of vascular biology
2. A macro and micro view of coronary vascular insult in ischaemic heart disease
3. Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death
4. Molecular bases of the acute coronary syndromes
5. Vulnerable plaque: Relation of characteristics to degree of stenosis in human coronary arteries
6. Compensatory enlargement of human atherosclerotic coronary arteries
7. Mechanisms of preconditioning: Correlates and epiphenomena
8. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The 4S study
9. The pathogenesis of coronary artery disease and the acute coronary syndromes
10. Factors influencing the presence or absence of acute coronary thrombi in sudden ischaemic death
11. Coronary plaque disruption
12. Angioscopic evaluation of coronary artery thrombi in acute coronary syndromes
13. Adhesion molecules, I
14. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques
15. Macrophage infiltration in acute coronary syndromes: Implication for plaque rupture
16. Gamma interferon regulates vascular smooth muscle proliferation and Ia expression in vivo and in vitro
17. Apoptosis of smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture
18. Coronary MR angiography during peak-systoles: Work in progress
19. Intravenous three-dimensional coronary angiography using contrast enhanced electron beam computed tomography
20. Imaging of coronary artery calcification. Its importance in assessing atherosclerotic disease
21. Differences in ultravascular plaque morphology in stable and unstable patients
22. Thermal detection of cellular infiltrates in living atherosclerotic plaques: Possible implications for plaque rupture and thrombosis
23. Thermal heterogeneity of human coronary arteries in acute myocardial infarction detected in vivo using a special thermography catheter
24. Fibrinolytic and inflammatory markers for arterial occlusion: The evolving epidemiology of thrombosis and haemostasis
25. Troponin T identifies patients with unstable coronary artery disease who benefit from long term antithrombotic protection
26. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. PRISM Study Investigators. Platelet Receptor Inhibition in Ischemic Syndrome Management
27. A classification of unstable angina revisited
28. Guidance on the use of glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromes
29. High sensitivity C-reactive protein (hs-CRP): A novel risk marker in cardiovascular disease
30. The unstable atherosclerotic plaque: Clinical significance and therapeutic intervention
31. Lipid lowering and plaque regression: New insights into prevention of plaque disruption and clinical events in coronary disease
32. Lipid lowering by diet reduces matrix metalloproteinases activity and increases collagen content of rabbit atheroma: A potential mechanism of lesion stabilisation
33. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion
34. Reduction in cardiovascular events during pravastatin therapy. Pooled analysis of clinical events of the pravastatin atherosclerosis intervention programme
35. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
36. Improved stenosis geometry by quantitative coronary arteriography after vigorous risk factor modification
37. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa
38. Inhibition of the platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes without persistent ST-segment elevation
39. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q wave myocardial infacrtion
40. An international randomised controlled trial of lamifiban, a platelet glycoprotein IIb/IIIa inhibitor, heparin or both in unstable angina
41. Antisense oligonucleotides as therapeutic agents - Is the bullet really magical